Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice

Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice

Memory impairments constitute a significant problem worldwide, and the COVID-19 pandemic dramatically increased the prevalence of cognitive deficits. Patients with cognitive deficits, specifically memory disturbances, have underlying comorbid conditions such as schizophrenia, anxiety, or depression....

Full description

Bibliographic Details
Main Authors:	Elżbieta Żmudzka, Klaudia Lustyk, Kinga Sałaciak, Agata Siwek, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Pharmaceuticals
Subjects:	anti-amnesic effect long-term memory cognition antidepressant-like activity serotonin receptors
Online Access:	https://www.mdpi.com/1424-8247/16/3/399

Similar Items

Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice
by: Elżbieta Żmudzka, et al.
Published: (2023-01-01)

Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents
by: Elżbieta Żmudzka, et al.
Published: (2022-12-01)

Novel Arylpiperazine Derivatives of Salicylamide with α<sub>1</sub>-Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats
by: Elżbieta Żmudzka, et al.
Published: (2022-12-01)

The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia
by: Klaudia Lustyk, et al.
Published: (2021-10-01)

Antioxidant Property of Jobelyn as the Possible Mechanism Underlying its Anti-amnesic Activity in Rodents
by: Solomon Umukoro, et al.
Published: (2013-02-01)

The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α<sub>1</sub>-Adrenolytic Properties
by: Klaudia Lustyk, et al.
Published: (2022-09-01)

Case Report: Cognitive Assessment Before an Amnesic Seizure in Transient Epileptic Amnesia Syndrome
by: Coline Bouyer, et al.
Published: (2022-07-01)

Paralytic and Amnesic Shellfish Toxins Impacts on Seabirds, Analyses and Management
by: Begoña Ben-Gigirey, et al.
Published: (2021-06-01)

HBK-10, A Compound with α<sub>1</sub>-Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats
by: Klaudia Lustyk, et al.
Published: (2022-10-01)

New, Eco-Friendly Method for Synthesis of 3-Chlorophenyl and 1,1′-Biphenyl Piperazinylhexyl Trazodone Analogues with Dual 5-HT<sub>1A</sub>/5-HT<sub>7</sub> Affinity and Its Antidepressant-like Activity
by: Przemysław Zaręba, et al.
Published: (2022-10-01)

Amnesic Shellfish Poisoning (ASP) and Paralytic Shellfish Poisoning (PSP) in Nigerian Coast, Gulf of Guinea
by: Medina Omo Kadiri, et al.
Published: (2018-12-01)

Impacts of Climate Change on the Biogeography of Three Amnesic Shellfish Toxin Producing Diatom Species
by: Francisco O. Borges, et al.
Published: (2022-12-01)

Effect of the antioxidant N-acetylcysteine on the depuration of the amnesic shellfish poisoning toxin, domoic acid, in the digestive gland of the king scallop Pecten maximus
by: Vanmaldergem Jean, et al.
Published: (2023-01-01)

Retrieval deficiency in brain activity of working memory in amnesic mild cognitive impairment patients: A brain event-related potentials study
by: Binyin eLi, et al.
Published: (2016-03-01)

The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders
by: Kinga Sałaciak, et al.
Published: (2021-04-01)

Low-Frequency Oscillations of In Vivo Ambient Extracellular Brain Serotonin
by: Colby E. Witt, et al.
Published: (2022-05-01)

Glioblastoma multiforme: Case report of an unusual presentation
by: Niveditha Samala, et al.
Published: (2023-01-01)

Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT<sub>1A</sub> and D<sub>2</sub> Receptors
by: Kinga Sałaciak, et al.
Published: (2021-07-01)

The pharmacological management of depression – Update 2017
by: Elzbieta Osuch, et al.
Published: (2017-03-01)

Antidepressants and cardiovascular adverse events: A narrative review
by: Mohammad Hassan Nezafati, et al.
Published: (2015-09-01)

Functional changes in the salience network of patients with amnesic mild cognitive impairment before and after repetitive transcranial magnetic stimulation
by: Qianqian Yuan, et al.
Published: (2023-09-01)

Therapeutic implications of the serotonin transporter gene in depression
by: Rif S. El-Mallakh, et al.
Published: (2019-12-01)

Antidepressants with antimicrobial activity? A promising therapeutic strategy
by: Gloria M. González, et al.
Published: (2022-07-01)

Rewiring of the Serotonin System in Major Depression
by: Faranak Vahid-Ansari, et al.
Published: (2021-12-01)

Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
by: Paola Bossù, et al.
Published: (2018-11-01)

Salicylamide
by: 982 SIRIM

The utility of PET imaging in depression
by: Shashi B. Singh, et al.
Published: (2024-04-01)

What Can Reinforcement Learning Models of Dopamine and Serotonin Tell Us about the Action of Antidepressants?
by: Denis C. L. Lan, et al.
Published: (2022-07-01)

The use of LeuT as a receptor model for antidepressant development
by: Lina Rustanti
Published: (2012-07-01)

Central Serotonin-2A (5-HT2A) Receptor Dysfunction in Depression and Epilepsy: The Missing Link?
by: Bruno Pierre Guiard, et al.
Published: (2015-03-01)

Antidepressant-Like Activity of Myelophil via Attenuation of Microglial-Mediated Neuroinflammation in Mice Undergoing Unpredictable Chronic Mild Stress
by: Jin-Seok Lee, et al.
Published: (2019-06-01)

Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression
by: Melodi A. Bowman, et al.
Published: (2019-02-01)

Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01)

Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
by: Kimford J. Meador
Published: (2014-01-01)

Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.
by: Nathan C Mitchell, et al.
Published: (2013-10-01)

Antioxidant Property of Jobelyn as the Possible Mechanism Underlying
by: Solomon Umukoro
Published: (2013-01-01)

Age and Sex as Determinants of Acute Domoic Acid Toxicity in a Mouse Model
by: Alicia M. Hendrix, et al.
Published: (2023-04-01)

Twenty-Five Years of Domoic Acid Monitoring in Galicia (NW Spain): Spatial, Temporal and Interspecific Variations
by: Juan Blanco, et al.
Published: (2021-10-01)

Amelioration of Cognitive Deficit by Embelin in a Scopolamine-Induced Alzheimer’s Disease-Like Condition in a Rat Model
by: Saatheeyavaane Bhuvanendran, et al.
Published: (2018-06-01)

Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies
by: Lisa Nicolai, et al.
Published: (2023-01-01)